AGF Logo
  • Home
  • Industry and Expert Views
  • Investing and Market Views
  • Capitol Insights
  • Français
  • AGF.com
Skip to content
AGF logo
Insights and Market Perspectives
  • Industry and Expert Views
  • Investing and Market Views
  • Capitol Insights
  • Contributors
  • Français
  • Search
Search
Close
background image tall buildings

About Ling Han

Ling Han

Ling Han, M.Sc., MBA, CFA®

Analyst

AGF Investments Inc.

Ling Han is an Analyst focused on the Chemicals and Healthcare sectors.

Ling brings more than a decade of investment experience to this role. Prior to joining AGF Investments, she worked as a consultant and as a sell-side equity research associate covering the North American Healthcare sector. Ling has also held a variety of roles at large financial institutions, banks and Canadian start-ups, gaining experience in risk and performance attribution analysis and corporate social responsibility/sustainability consulting.

Ling holds a B.Sc. degree in Electronic Engineering from Peking University in Beijing. She also earned a Master’s degree in Engineering Physics from McMaster University and an MBA from Boston University.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

Recent Articles from this contributor
post image U.S. Healthcare Stocks and the U.S. Presidential Election

  • Investing and Market Views

U.S. Healthcare Stocks and the U.S. Presidential Election

October 16, 2024

AGF Investments Inc. analyst Ling Han discusses the potential election impact to managed care stocks and other segments of the…

post image An Investor’s Guide to GLP-1 Drugs: Beyond Biopharma Stocks

  • Investing and Market Views

An Investor’s Guide to GLP-1 Drugs: Beyond Biopharma Stocks

July 3, 2024

In part one of a series, analyst Ling Han discusses the potential impact of GLP-1 drugs to healthcare stocks not directly involved in the development and manufacture of the medical world’s latest pharmaceutical phenomenon

post image GLP-1: Healthcare’s Latest Investment Mega Theme

  • Investing and Market Views

GLP-1: Healthcare’s Latest Investment Mega Theme

May 14, 2024

AGF analyst Ling Han discusses the pharmaceutical drug front and center with healthcare investors.

AGF Logo
  • Industry and Expert Views
  • Investing and Market Views
  • Capitol Insights

Follow AGF

© 2025 AGF Management Limited. All rights reserved.

  • Terms & Conditions
  • Privacy
  • AGF.com